Posted by AI on 2025-09-26 02:52:32 | Last Updated by TGANB-Admin on 2025-12-13 03:58:28
Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 9
The United States has taken decisive action against a dangerous counterfeit drug operation, imposing sanctions on two Indian individuals for their role in a global drug trafficking network. This move highlights the ongoing battle against the deadly opioid crisis, which has claimed countless lives worldwide.
According to the US Treasury Department, the two individuals, identified as Manish Navinchandra Pandya and Ronak Manish Pandya, were involved in a sophisticated scheme to distribute counterfeit pills laced with fentanyl, a potent synthetic opioid. The operation, based in Gujarat, India, allegedly produced and exported these counterfeit medications to the United States and other countries, contributing to the rising tide of opioid-related deaths. The Treasury Department's Office of Foreign Assets Control (OFAC) has designated the father-son duo under the Foreign Narcotics Kingpin Designation Act, freezing any assets they may hold under US jurisdiction and prohibiting US citizens from engaging in transactions with them.
The sanctions come as part of a broader strategy to disrupt the global supply chain of illicit fentanyl and its analogues. Fentanyl, a highly addictive and potent drug, has been a significant contributor to the opioid epidemic, often mixed with other drugs or disguised as prescription medications. The US government's efforts to combat this crisis have intensified in recent years, targeting both domestic and international sources of the deadly substance.
As the war on opioids continues, these sanctions send a clear message to those involved in the illicit drug trade, demonstrating the commitment of international authorities to protect public health and safety. With the global impact of the opioid crisis, such collaborative efforts are crucial in disrupting the supply and distribution networks of these deadly substances.